Cartesian Therapeutics
RNAC
RNAC
95 hedge funds and large institutions have $154M invested in Cartesian Therapeutics in 2020 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 36 increasing their positions, 23 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
95
Holders Change
+16
Holders Change %
+20.25%
% of All Funds
1.69%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
26
Increased
36
Reduced
23
Closed
10
Calls
$353K
Puts
$564K
Net Calls
-$211K
Net Calls Change
-$475K
Top Buyers
| 1 |
AC
Armistice Capital
New York
|
+$4.96M |
| 2 |
Morgan Stanley
New York
|
+$3.96M |
| 3 |
BlackRock
New York
|
+$3.21M |
| 4 |
Two Sigma Investments
New York
|
+$2.82M |
| 5 |
JPMorgan Chase & Co
New York
|
+$2.68M |
Top Sellers
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$15.6M |
| 2 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
-$15.4M |
| 3 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$5.86M |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$5.13M |
| 5 |
O
OrbiMed
New York
|
-$4.71M |
